IPOGrid
0001822691
IPO filing research

GreenLight Biosciences Holdings, PBC

Biological Products, (No Diagnostic Substances)

follow-on priced EFFECT

GreenLight Biosciences Holdings, PBC IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: EFFECT on 2023-07-25.

Filing Timeline

SEC EDGAR
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-07-25 · 9999999995-23-002185
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-07-25 · 9999999995-23-002181
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2023-03-30 · 9999999995-23-000739
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-03-09 · 0000950170-23-006832
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-03-07 · 0000950170-23-006376
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-02-01 · 0000950170-23-001526
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-01-09 · 0000950170-23-000435
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-11-09 · 0000950170-22-024002
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-10-12 · 0000950170-22-019477
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-10-06 · 0001193125-22-258940
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-10-05 · 9999999995-22-002942
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
2022-09-26 · 0001193125-22-251333
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
2022-09-26 · 0001193125-22-251296
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-08-15 · 0000950170-22-017321
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-06-01 · 0000950170-22-010985
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-05-18 · 0000950170-22-010227
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-04-07 · 0001193125-22-098850
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-04-06 · 9999999995-22-000842
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-03-17 · 0001193125-22-077812
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-02-15 · 0001193125-22-043188
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2022-02-14 · 9999999995-22-000462
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 425 in the pre-IPO sequence.
2022-02-07 · 0001193125-22-029838
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-02-02 · 0001193125-22-025272
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-01-28 · 0001193125-22-020902
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows EFFECT in the pre-IPO sequence.
2022-01-21 · 0001193125-22-014159
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-01-13 · 9999999995-22-000126
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-4/A and confirms the priced prospectus.
2022-01-13 · 0001193125-22-008675
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2022-01-13 · 0001193125-22-007945
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2022-01-10 · 0001193125-22-005877
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-01-05 · 0001193125-22-002798
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2022-01-05 · 0001193125-22-002751
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2021-12-23 · 0001193125-21-366371
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2021-12-06 · 0001193125-21-348562
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2021-11-23 · 0001193125-21-338485
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2021-10-21 · 0001193125-21-303340
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2021-10-21 · 0001193125-21-303339
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4 filing.
2021-10-19 · 0001193125-21-301564
S-4 filed
S-4
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2021-09-07 · 0001193125-21-266723
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B4 in the pre-IPO sequence.
2021-08-10 · 0001193125-21-242032
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows CERT and confirms the priced prospectus.
2021-01-15 · 0001213900-21-002606
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows EFFECT in the pre-IPO sequence.
2021-01-14 · 0001354457-21-000060
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 8-A12B and marks the registration effective.
2021-01-13 · 9999999995-21-000141
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows S-1/A and registers the class of securities for exchange listing.
2021-01-13 · 0001213900-21-001986
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2021-01-11 · 0001213900-21-001300
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2020-12-21 · 0001213900-20-043891
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2020-09-18 · 0001213900-20-027406
Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 20 using nearest neighbors.
Showing top 8 by similarity.
+9.1%
Median day-1
60%
Above issue
+0.7%
Median week-1
-20.9%
Downside (p10)
Attovia Therapeutics, Inc. ATTO
2026-08-05 $269M Day 1: +28.8% Wk 1: +18.6%
same SICrecent IPO
Scribe Therapeutics, Inc. SCTX
2026-07-24 $129M Day 1: +44.3% Wk 1: +37.2%
same SICrecent IPO
Odyssey Therapeutics, Inc. ODTX
2026-05-08 $279M Day 1: -8.8% Wk 1: -3.8%
same SICrecent IPO
Hemab Therapeutics Holdings, Inc. COAG
2026-05-01 $302M Day 1: +88.9% Wk 1: +43.0%
same SICrecent IPO
BlossomHill Therapeutics, Inc. BLSM
2026-08-07 $150M Day 1: +0.0% Wk 1: +0.0%
same SIC grouprecent IPO
Latigo Biotherapeutics, Inc. LTGO
2026-08-07 $346M Day 1: +1.4% Wk 1: +1.4%
same SIC grouprecent IPO
Braveheart Bio, Inc. BRVE
2026-08-06 $383M Day 1: +65.6% Wk 1: +66.7%
same SIC grouprecent IPO
Apnimed, Inc. APMD
2026-07-31 $192M Day 1: +43.6% Wk 1: +74.3%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.